
    
      This is a randomized, double-blind, vehicle-controlled, parallel group study. During this
      study, the investigator will identify 4 eligible SK Target Lesions on each subject on the
      trunk, extremities and face. The Target Lesions will be treated, by an investigational staff
      member other than the evaluating investigator, a maximum of two times.
    
  